Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol
Open Access

Amir RA

Publications

• Research Article
  Prenatal Exposure of Kisspeptin Antagonist on the GonadotropinReleasing Hormone (GnRH) Expression in Rat Model of Polycystic Ovary Syndrome
  Author(s): Sareh Z, Azita Zadeh-V, Mahsa N, Razieh Bidhendi Y, Asghar G, Amir RA and Fahimeh Ramezani TSareh Z, Azita Zadeh-V, Mahsa N, Razieh Bidhendi Y, Asghar G, Amir RA and Fahimeh Ramezani T
  
  Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. Increased GnRH/luteinizing hormone (LH) pulse frequency is a characteristic of endocrine abnormalities in PCOS. Kisspeptin antagonists reduce LH pulse frequency and amplitude and are hence supposed to slow GnRH neuron activity that may adjust GnRH/LH levels in PCOS conditions.Objective: To investigate the impact of kisspeptin antagonist P271 administration during prenatal life to reduce GnRH expression in adulthood in prenatally androgenized (PNA) rats as a model of PCOS.Materials and methods: PNA rats (n=9) and controls (n=9) received P271 on day 20 of their prenatal life, and they were examined in adulthood (110-120 days). The ability of P271 to alter GnRH mRNA expression, and plasma levels of gonado.. View More»
  DOI: 10.4172/2375-4508.1000206

  Abstract PDF

Relevant Topics